SCHEMBL1506775

SCHEMBL1506775

O=c1[nH]c(Nc2ccccc2)nc2c1ncn2CCCCO

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TK1 P04183 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8535266 0.92 TK1 (0.85) TK1
SCHEMBL8536217 0.89 TK1 (0.80) TK1
SCHEMBL7688901 0.83 TK1 (0.70) TK1
SCHEMBL17485742 0.82 TK1 (0.70) TK1
SCHEMBL8539795 0.81 TK1 (0.69) TK1
SCHEMBL8537887 0.81 TK1 (0.68) TK1
SCHEMBL8535784 0.79 TK1 (0.65) TK1
SCHEMBL8536600 0.77 TK1 (0.63) TK1
SCHEMBL8536577 0.76 TK1 (0.61) TK1
SCHEMBL571645 0.76 TK1 (1.00) TK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7727995-B2 Antiherpes drug combinations UNIVERSITY OF MASSACHUSETTS (US) 2010-06-01 US claimed
EP-1594507-A4 NOVEL ANTIHERPES DRUG COMBINATIONS UNIV MASSACHUSETTS (US) 2008-10-01 EP claimed
EP-1594507-A2 NOVEL ANTIHERPES DRUG COMBINATIONS The University of Massachussetts (US) 2005-11-16 EP claimed
US-20040259832-A1 Novel antiherpes drug combinations NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2004-12-23 US claimed
WO-2004069168-A2 NOVEL ANTIHERPES DRUG COMBINATIONS UNIVERSITY OF MASSACHUSETTS (US) 2004-08-19 WO claimed
EP-3433284-B1 MODIFIED HYALURONIC ACID, METHOD FOR MAKING SAME AND USES THEREOF MERZ PHARMA GMBH & CO KGAA (DE) 2026-05-06 EP disclosed
EP-4662319-A2 PERSONALIZED CRISPR PROFILING FOR CANCER Integrate Bioscience LLC (US) 2025-12-17 EP disclosed
CN-120678721-B Wound antibacterial disinfection gel and preparation method thereof 平阳县人民医院 2025-10-21 CN disclosed
CN-120678721-A Wound antibacterial disinfection gel and preparation method thereof 平阳县人民医院 2025-09-23 CN disclosed
US-12214011-B2 Selective cell death-inducing enzyme system TOUREL, Sylvain (DE) 2025-02-04 US disclosed
WO-2024248455-A1 ORGANIC MATERIAL FOR SEMICONDUCTOR CMP, AND SLURRY COMPOSITION COMPRISING SAME 연세대학교 산학협력단 2024-12-05 WO disclosed
WO-2024168301-A2 PERSONALIZED CRISPR PROFILING FOR CANCER FUNCTION ONCOLOGY, INC. (US) 2024-08-15 WO disclosed
EP-1670507-A2 VACCINE FOR TREATMENT AND PREVENTION OF HERPES SIMPLEX VIRUS INFECTION Antigenics Inc. (US) 2006-06-21 EP disclosed
EP-1594507-A2 NOVEL ANTIHERPES DRUG COMBINATIONS The University of Massachussetts (US) 2005-11-16 EP disclosed
WO-2005028496-A2 VACCINE FOR TREATMENT AND PREVENTION OF HERPES SIMPLEX VIRUS INFECTION ANTIGENICS, INC. (US) 2005-03-31 WO disclosed
US-20040259832-A1 Novel antiherpes drug combinations NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2004-12-23 US disclosed
WO-2004069168-A2 NOVEL ANTIHERPES DRUG COMBINATIONS UNIVERSITY OF MASSACHUSETTS (US) 2004-08-19 WO disclosed
EP-0794781-A4 DRUGS TO PREVENT RECURRENT HERPES VIRUS INFECTIONS UNIV MASSACHUSETTS MEDICAL (US) 1998-04-22 EP disclosed
EP-0794781-A1 DRUGS TO PREVENT RECURRENT HERPES VIRUS INFECTIONS UNIVERSITY OF MASSACHUSETTS MEDICAL CENTER (US) 1997-09-17 EP disclosed
WO-1996020711-A1 DRUGS TO PREVENT RECURRENT HERPES VIRUS INFECTIONS UNIVERSITY OF MASSACHUSETTS MEDICAL CENTER (US) 1996-07-11 WO disclosed